Raymond James Trust’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.21M Sell
26,768
-2,324
-8% -$174K 0.05% 303
2024
Q2
$2.04M Sell
29,092
-472
-2% -$33.7K 0.05% 313
2024
Q1
$2.19M Buy
29,564
+676
+2% +$47.1K 0.05% 300
2023
Q4
$1.91M Sell
28,888
-560
-2% -$35K 0.05% 307
2023
Q3
$1.85M Sell
29,448
-1,631
-5% -$102K 0.06% 291
2023
Q2
$1.76M Sell
31,079
-2,026
-6% -$112K 0.05% 303
2023
Q1
$1.92M Sell
33,105
-799
-2% -$53.9K 0.06% 270
2022
Q4
$2.45M Sell
33,904
-585
-2% -$41.9K 0.08% 219
2022
Q3
$2.1M Sell
34,489
-1,661
-5% -$106K 0.08% 229
2022
Q2
$2.27M Sell
36,150
-6,828
-16% -$452K 0.08% 225
2022
Q1
$3.02M Buy
42,978
+3,993
+10% +$270K 0.09% 205
2021
Q4
$2.44M Sell
38,985
-1,132
-3% -$71K 0.07% 234
2021
Q3
$2.48M Sell
40,117
-1,797
-4% -$108K 0.08% 210
2021
Q2
$2.51M Sell
41,914
-3,582
-8% -$227K 0.08% 210
2021
Q1
$2.77M Buy
45,496
+2,600
+6% +$143K 0.1% 188
2020
Q4
$2.01M Sell
42,896
-6,267
-13% -$272K 0.08% 223
2020
Q3
$1.83M Buy
49,163
+759
+2% +$28.8K 0.08% 214
2020
Q2
$1.77M Buy
48,404
+1,569
+3% +$54.6K 0.09% 204
2020
Q1
$1.43M Sell
46,835
-3,784
-7% -$168K 0.08% 211
2019
Q4
$2.58M Buy
50,619
+1,391
+3% +$67.1K 0.12% 164
2019
Q3
$2.32M Sell
49,228
-321
-0.6% -$15.3K 0.12% 172
2019
Q2
$2.46M Sell
49,549
-4,157
-8% -$195K 0.14% 155
2019
Q1
$2.29M Sell
53,706
-1,206
-2% -$53.3K 0.13% 166
2018
Q4
$2.25M Sell
54,912
-16,623
-23% -$713K 0.15% 149
2018
Q3
$3.34M Sell
71,535
-1,333
-2% -$60.9K 0.19% 119
2018
Q2
$3.18M Sell
72,868
-1,902
-3% -$88.7K 0.19% 115
2018
Q1
$3.43M Buy
74,770
+5,750
+8% +$279K 0.24% 98
2017
Q4
$3.49M Buy
69,020
+685
+1% +$36.1K 0.23% 101
2017
Q3
$3.55M Sell
68,335
-3,424
-5% -$167K 0.25% 99
2017
Q2
$3.51M Buy
71,759
+665
+0.9% +$30.8K 0.26% 99
2017
Q1
$3.35M Sell
71,094
-3,185
-4% -$152K 0.25% 101
2016
Q4
$3.57M Buy
74,279
+10,032
+16% +$460K 0.28% 92
2016
Q3
$2.54M Buy
64,247
+7,988
+14% +$300K 0.22% 109
2016
Q2
$2M Buy
56,259
+2,827
+5% +$110K 0.18% 130
2016
Q1
$2.09M Buy
53,432
+2,913
+6% +$109K 0.2% 117
2015
Q4
$2.17M Sell
50,519
-49,147
-49% -$2.16M 0.2% 120
2015
Q3
$4.19M Buy
99,666
+5,838
+6% +$273K 0.47% 54
2015
Q2
$4.68M Sell
93,828
-384
-0.4% -$18.2K 0.5% 51
2015
Q1
$4.25M Buy
94,212
+7,220
+8% +$324K 0.45% 54
2014
Q4
$4.19M Buy
86,992
+2,124
+3% +$101K 0.45% 59
2014
Q3
$4.06M Sell
84,868
-516
-0.6% -$25.1K 0.47% 54
2014
Q2
$4.23M Buy
85,384
+2,943
+4% +$138K 0.48% 53
2014
Q1
$3.88M Buy
82,441
+7,513
+10% +$345K 0.48% 54
2013
Q4
$3.6M Buy
74,928
+50,318
+204% +$2.26M 0.47% 57
2013
Q3
$1.03M Buy
24,610
+2,348
+11% +$101K 0.16% 145
2013
Q2
$907K Buy
+22,262
New +$819K 0.15% 150

Other funds holding MET

Raymond James Trust's MET Position: Q3 2024 in Review

Raymond James Trust reduced its MetLife (MET) stake by 8% in Q3 2024, selling an estimated $174K and leaving 26,768 shares worth $2.21M. The position accounts for 0.05% of the portfolio, ranked #303.

Raymond James Trust first reported a position in MET in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.68M in Q2 2015. 1,315 funds tracked by Wall St. Rank hold MET as of Q3 2024.

  • Raymond James Trust held 26,768 shares of MetLife worth $2.21M as of Q3 2024.
  • Raymond James Trust sold 2,324 MetLife shares in Q3 2024, an estimated $174K.
  • MetLife made up 0.05% of Raymond James Trust's portfolio in Q3 2024, its #303 holding.
  • Raymond James Trust first reported a position in MetLife in Q2 2013 and has held it in 46 quarters since.
  • Raymond James Trust's MetLife position peaked at $4.68M in Q2 2015.
  • 1,315 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.